NO20044814L - Fremgangsmate for fremstilling av combretastaniner - Google Patents
Fremgangsmate for fremstilling av combretastaninerInfo
- Publication number
- NO20044814L NO20044814L NO20044814A NO20044814A NO20044814L NO 20044814 L NO20044814 L NO 20044814L NO 20044814 A NO20044814 A NO 20044814A NO 20044814 A NO20044814 A NO 20044814A NO 20044814 L NO20044814 L NO 20044814L
- Authority
- NO
- Norway
- Prior art keywords
- combretastanines
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0204499A FR2838437B1 (fr) | 2002-04-11 | 2002-04-11 | Procedes de preparation de combretastatines |
| PCT/FR2003/001117 WO2003084919A2 (fr) | 2002-04-11 | 2003-04-09 | Procedes de preparation de combretastatines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20044814L true NO20044814L (no) | 2004-01-07 |
| NO329701B1 NO329701B1 (no) | 2010-12-06 |
Family
ID=28459732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20044814A NO329701B1 (no) | 2002-04-11 | 2004-11-05 | Fremgangsmate for fremstilling av combretastaniner og mellomprodukt for fremgangsmaten |
| NO20101215A NO331372B1 (no) | 2002-04-11 | 2010-09-01 | Fremgangsmate for fremstilling av combretastatiner |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20101215A NO331372B1 (no) | 2002-04-11 | 2010-09-01 | Fremgangsmate for fremstilling av combretastatiner |
Country Status (28)
| Country | Link |
|---|---|
| EP (3) | EP1497255A2 (no) |
| JP (1) | JP4299677B2 (no) |
| KR (1) | KR101018983B1 (no) |
| CN (1) | CN1291970C (no) |
| AR (2) | AR039198A1 (no) |
| AU (1) | AU2003260026B2 (no) |
| BR (1) | BR0309087A (no) |
| CA (1) | CA2481742C (no) |
| CR (1) | CR7481A (no) |
| EA (1) | EA007965B1 (no) |
| EC (1) | ECSP045348A (no) |
| FR (1) | FR2838437B1 (no) |
| HK (1) | HK1075651A1 (no) |
| HR (1) | HRP20040935A2 (no) |
| IL (1) | IL164247A0 (no) |
| MA (1) | MA26407A1 (no) |
| ME (1) | MEP91508A (no) |
| MX (1) | MXPA04009112A (no) |
| NO (2) | NO329701B1 (no) |
| NZ (1) | NZ535318A (no) |
| OA (1) | OA12804A (no) |
| PL (3) | PL213708B1 (no) |
| RS (3) | RS20110562A3 (no) |
| TN (1) | TNSN04201A1 (no) |
| TW (1) | TWI262179B (no) |
| UA (1) | UA76079C2 (no) |
| WO (1) | WO2003084919A2 (no) |
| ZA (1) | ZA200407417B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235688B1 (en) | 2004-11-04 | 2007-06-26 | University Of Notre Dame Du Lac | Process for preparing histone deacetylase inhibitors and intermediates thereof |
| FR2928148B1 (fr) * | 2008-02-28 | 2013-01-18 | Sanofi Aventis | Procede de preparation de combretastatine |
| FR2939665B1 (fr) | 2008-12-12 | 2011-10-07 | Sanofi Aventis | Combinaison antitumorale associant l'ave8062a et le docetaxel |
| FR2945210B1 (fr) | 2009-05-07 | 2011-07-01 | Sanofi Aventis | Combinaison antitumorale comprenant l'ave8062 et le sorafenib |
| FR2953518B1 (fr) | 2009-12-03 | 2012-01-20 | Sanofi Aventis | Procede de preparation d'un derive de combretastatine |
| EP2481404A1 (en) | 2010-11-15 | 2012-08-01 | Sanofi | An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative |
| MX2012014732A (es) | 2010-06-18 | 2013-01-22 | Sanofi Sa | Una combinacion antitumoral que comprende ombrabulina un derivado de taxano y un derivado de platino. |
| EP2397135A1 (en) | 2010-06-18 | 2011-12-21 | Sanofi | An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative |
| EP2407161A1 (en) | 2010-07-13 | 2012-01-18 | Sanofi | An antitumoral combination comprising ombrabulin and bevacizumab |
| FR2968557A1 (fr) | 2010-12-09 | 2012-06-15 | Sanofi Aventis | Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab |
| FR2978663A1 (fr) | 2011-08-01 | 2013-02-08 | Sanofi Sa | Combinaison antitumorale comprenant l'ombrabuline et le cetuximab, associee a la radiotherapie |
| FR2978662A1 (fr) | 2011-08-01 | 2013-02-08 | Sanofi Sa | Combinaison antitumorale comprenant l'ombrabuline et le cisplatine, associee a la radiotherapie |
| CN103012248B (zh) * | 2013-01-11 | 2014-11-05 | 浙江大德药业集团有限公司 | 氨基康普立停衍生物的合成及其作为口服抗肿瘤药物的应用 |
| EP3184095A1 (en) | 2013-05-23 | 2017-06-28 | IP Gesellschaft für Management mbH | Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide |
| EP4079327A1 (en) | 2021-04-22 | 2022-10-26 | Centaurus Polytherapeutics | Payloads for drug-conjugates and their use for treating cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996237A (en) | 1987-01-06 | 1991-02-26 | Arizona Board Of Regents | Combretastatin A-4 |
| SU1766257A3 (ru) * | 1988-02-24 | 1992-09-30 | Ф.Хоффманн-Ля Рош Аг (Фирма) | Способ получени производных стильбена |
| NZ232897A (en) * | 1989-04-03 | 1992-12-23 | Squibb & Sons Inc | Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogues, preparation and pharmaceutical compositions thereof |
| TW325458B (en) | 1993-09-08 | 1998-01-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer |
| US5731353A (en) * | 1993-09-08 | 1998-03-24 | Ajinomoto Co., Inc. | Stilbene derivatives and pharmaceutical compositions containing them |
| JP3080405B2 (ja) * | 1994-04-06 | 2000-08-28 | 日本新薬株式会社 | アミノスチルバゾール誘導体及び医薬 |
| TW334418B (en) * | 1995-03-07 | 1998-06-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions |
| JP4551514B2 (ja) * | 1999-07-23 | 2010-09-29 | 住友化学株式会社 | 不飽和炭化水素残基置換アニリン類の製造方法 |
| GB9918912D0 (en) | 1999-08-12 | 1999-10-13 | Angiogene Pharm Ltd | New stilbenes with vascular damaging activity |
-
2002
- 2002-04-11 FR FR0204499A patent/FR2838437B1/fr not_active Expired - Fee Related
-
2003
- 2003-03-28 AR ARP030101111A patent/AR039198A1/es active IP Right Grant
- 2003-04-09 RS RS20110562A patent/RS20110562A3/en unknown
- 2003-04-09 KR KR1020047016132A patent/KR101018983B1/ko not_active IP Right Cessation
- 2003-04-09 JP JP2003582118A patent/JP4299677B2/ja not_active Expired - Fee Related
- 2003-04-09 BR BR0309087-6A patent/BR0309087A/pt not_active IP Right Cessation
- 2003-04-09 EP EP03740582A patent/EP1497255A2/fr not_active Withdrawn
- 2003-04-09 RS RS20110561A patent/RS20110561A3/en unknown
- 2003-04-09 EP EP10183135A patent/EP2354118A1/fr not_active Withdrawn
- 2003-04-09 CA CA2481742A patent/CA2481742C/fr not_active Expired - Fee Related
- 2003-04-09 PL PL371629A patent/PL213708B1/pl not_active IP Right Cessation
- 2003-04-09 WO PCT/FR2003/001117 patent/WO2003084919A2/fr active Application Filing
- 2003-04-09 PL PL394821A patent/PL214129B1/pl not_active IP Right Cessation
- 2003-04-09 NZ NZ535318A patent/NZ535318A/en not_active IP Right Cessation
- 2003-04-09 IL IL16424703A patent/IL164247A0/xx not_active IP Right Cessation
- 2003-04-09 OA OA1200400275A patent/OA12804A/fr unknown
- 2003-04-09 EA EA200401350A patent/EA007965B1/ru not_active IP Right Cessation
- 2003-04-09 AU AU2003260026A patent/AU2003260026B2/en not_active Ceased
- 2003-04-09 PL PL394820A patent/PL213967B1/pl not_active IP Right Cessation
- 2003-04-09 MX MXPA04009112A patent/MXPA04009112A/es active IP Right Grant
- 2003-04-09 ME MEP-915/08A patent/MEP91508A/xx unknown
- 2003-04-09 RS YU86504A patent/RS52331B/en unknown
- 2003-04-09 EP EP10183123A patent/EP2348012A1/fr not_active Withdrawn
- 2003-04-09 CN CNB038075660A patent/CN1291970C/zh not_active Expired - Fee Related
- 2003-04-10 TW TW092108184A patent/TWI262179B/zh not_active IP Right Cessation
- 2003-09-04 UA UA20041109227A patent/UA76079C2/uk unknown
-
2004
- 2004-09-14 CR CR7481A patent/CR7481A/es unknown
- 2004-09-15 ZA ZA200407417A patent/ZA200407417B/en unknown
- 2004-09-20 MA MA27868A patent/MA26407A1/fr unknown
- 2004-10-07 HR HR20040935A patent/HRP20040935A2/hr not_active Application Discontinuation
- 2004-10-08 EC EC2004005348A patent/ECSP045348A/es unknown
- 2004-10-08 TN TNP2004000201A patent/TNSN04201A1/fr unknown
- 2004-11-05 NO NO20044814A patent/NO329701B1/no not_active IP Right Cessation
-
2005
- 2005-09-05 HK HK05107764A patent/HK1075651A1/xx not_active IP Right Cessation
-
2010
- 2010-09-01 NO NO20101215A patent/NO331372B1/no not_active IP Right Cessation
-
2011
- 2011-08-05 AR ARP110102854A patent/AR082581A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20050136D0 (no) | Fremgangsmate for fremstilling av mikropartikler | |
| NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
| NO20070753L (no) | Fremgangsmåte for fremstilling av dihydropteridinoner | |
| NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
| DK1546122T3 (da) | Fremgangsmåde til fremstilling af valsartan | |
| NO20052807D0 (no) | Fremgangsmate for fremstilling av aminosyrer | |
| NO20043586L (no) | Fremgangsmate for fremstilling av organiske forbindelser | |
| NO20040027L (no) | Fremgangsmate for fremstillingen av escitalopram | |
| NO20040278L (no) | Fremgangsmate for fremstilling av perindopril | |
| NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
| NO20033408D0 (no) | Fremgangsmåte for fremstilling av krystallinske nanopartikler | |
| NO20052471D0 (no) | Fremgangsmate for fremstilling av 3-metyltiopropanal. | |
| FI20011889A (fi) | Menetelmä ksylitolin valmistamiseksi | |
| NO20041850L (no) | Fremgangsmate for dannelse av profenkrystaller | |
| NO20035538D0 (no) | Fremgangsmåte for fremstilling av zaleplon | |
| NO20042640L (no) | Fremgangsmate for fremstilling av ekinocandinderivater | |
| NO20023445L (no) | Fremgangsmåte for fremstilling av peptider | |
| NO20034597D0 (no) | Fremgangsmåte for fremstilling av cantaxantin | |
| NO20035586L (no) | Fremgangsmate for fremstilling av cykloheksanol-derivater | |
| NO20035136D0 (no) | Fremgangsmåte til fremstilling av imipenem | |
| DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
| NO20044332L (no) | Forbedret fremgangsmate for fremstilling av nevirapine | |
| NO20030515D0 (no) | Fremgangsmåte for fremstilling av dinapsolin | |
| NO20052396D0 (no) | Fremgangsmate for fremstilling av spirolactonforbindelser | |
| NO20043455L (no) | Fremgangsmate for fremstilling av 7alfa-metylsteroider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |